Post by Gubra

We are pleased to announce that Jens Bjelke Kristensen has successfully defended his industrial PhD dissertation: “Opportunities and Limitations with Peptide Therapeutics in Migraine and Metabolic Dysfunction-associated Steatohepatitis.” Jens’ research journey spanned systemic characterization of peptide-based CGRP receptor antagonists for migraine, novel CGRP biology, and in-depth translational preclinical research in MASH. A strong example of how drug discovery programs evolve through science-driven decisions, ultimately resulting in three impactful publications. Congratulations to Jens on this impressive achievement! #DrugDiscovery #PeptideTherapeutics #MigraineResearch #MASH #TranslationalResearch #IndustrialPhD